ID   IRS1_RAT                Reviewed;        1235 AA.
AC   P35570;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   02-OCT-2024, entry version 187.
DE   RecName: Full=Insulin receptor substrate 1;
DE            Short=IRS-1;
DE   AltName: Full=pp185;
GN   Name=Irs1; Synonyms=Irs-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=1648180; DOI=10.1038/352073a0;
RA   Sun X.-J., Rothenberg P.L., Kahn C.R., Backer J.M., Araki E., Wilden P.A.,
RA   Cahill D.A., Goldstein B.J., White M.F.;
RT   "Structure of the insulin receptor substrate IRS-1 defines a unique signal
RT   transduction protein.";
RL   Nature 352:73-77(1991).
RN   [2]
RP   PROTEIN SEQUENCE OF 44-51; 173-178; 223-243; 489-506; 635-646; 932-947 AND
RP   1098-1106.
RX   PubMed=2022647; DOI=10.1016/s0021-9258(18)92976-5;
RA   Rothenberg P.L., Lane W.S., Karasik A., Backer J.M., White M.F., Kahn C.R.;
RT   "Purification and partial sequence analysis of pp185, the major cellular
RT   substrate of the insulin receptor tyrosine kinase.";
RL   J. Biol. Chem. 266:8302-8311(1991).
RN   [3]
RP   FUNCTION, PHOSPHORYLATION, AND INTERACTION WITH PIK3R1.
RX   PubMed=1380456; DOI=10.1002/j.1460-2075.1992.tb05426.x;
RA   Backer J.M., Myers M.G. Jr., Shoelson S.E., Chin D.J., Sun X.-J.,
RA   Miralpeix M., Hu P., Margolis B., Skolnik E.Y., Schlessinger J.,
RA   White M.F.;
RT   "Phosphatidylinositol 3'-kinase is activated by association with IRS-1
RT   during insulin stimulation.";
RL   EMBO J. 11:3469-3479(1992).
RN   [4]
RP   INTERACTION WITH GRB2.
RX   PubMed=8491186; DOI=10.1002/j.1460-2075.1993.tb05842.x;
RA   Skolnik E.Y., Lee C.-H., Batzer A.G., Vicentini L.M., Zhou M., Daly R.J.,
RA   Myers M.J. Jr., Backer J.M., Ullrich A., White M.F., Schlessinger J.;
RT   "The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-
RT   phosphorylated IRS1 and Shc: implications for insulin control of ras
RT   signalling.";
RL   EMBO J. 12:1929-1936(1993).
RN   [5]
RP   PHOSPHORYLATION AT TYR-460; TYR-608; TYR-628; TYR-895; TYR-939; TYR-987;
RP   TYR-1172 AND TYR-1222.
RX   PubMed=7504175; DOI=10.1128/mcb.13.12.7418-7428.1993;
RA   Sun X.-J., Crimmins D.L., Myers M.G. Jr., Miralpeix M., White M.F.;
RT   "Pleiotropic insulin signals are engaged by multisite phosphorylation of
RT   IRS-1.";
RL   Mol. Cell. Biol. 13:7418-7428(1993).
RN   [6]
RP   PHOSPHORYLATION AT SER-99 AND THR-502.
RX   PubMed=8349691; DOI=10.1016/s0021-9258(17)46824-4;
RA   Tanasijevic M.J., Myers M.G. Jr., Thoma R.S., Crimmins D.L., White M.F.,
RA   Sacks D.B.;
RT   "Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase
RT   II.";
RL   J. Biol. Chem. 268:18157-18166(1993).
RN   [7]
RP   INTERACTION WITH PHIP, AND MUTAGENESIS OF TRP-106.
RX   PubMed=11018022; DOI=10.1074/jbc.c000611200;
RA   Farhang-Fallah J., Yin X., Trentin G., Cheng A.M., Rozakis-Adcock M.;
RT   "Cloning and characterization of PHIP, a novel insulin receptor substrate-1
RT   pleckstrin homology domain interacting protein.";
RL   J. Biol. Chem. 275:40492-40497(2000).
RN   [8]
RP   PHOSPHORYLATION AT SER-307.
RX   PubMed=11606564; DOI=10.1074/jbc.m101521200;
RA   Aguirre V., Werner E.D., Giraud J., Lee Y.H., Shoelson S.E., White M.F.;
RT   "Phosphorylation of Ser307 in insulin receptor substrate-1 blocks
RT   interactions with the insulin receptor and inhibits insulin action.";
RL   J. Biol. Chem. 277:1531-1537(2002).
RN   [9]
RP   PHOSPHORYLATION AT SER-789.
RX   PubMed=12006586; DOI=10.1074/jbc.m201494200;
RA   Qiao L.Y., Zhande R., Jetton T.L., Zhou G., Sun X.-J.;
RT   "In vivo phosphorylation of insulin receptor substrate 1 at serine 789 by a
RT   novel serine kinase in insulin-resistant rodents.";
RL   J. Biol. Chem. 277:26530-26539(2002).
RN   [10]
RP   INTERACTION WITH ROCK1, AND PHOSPHORYLATION.
RX   PubMed=11739394; DOI=10.1074/jbc.m110508200;
RA   Begum N., Sandu O.A., Ito M., Lohmann S.M., Smolenski A.;
RT   "Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1
RT   and inhibits insulin signaling in vascular smooth muscle cells.";
RL   J. Biol. Chem. 277:6214-6222(2002).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-343; THR-441; THR-448
RP   AND SER-891, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [12]
RP   PHOSPHORYLATION AT SER-612.
RX   PubMed=24187137; DOI=10.1074/jbc.m113.500736;
RA   Seldin M.M., Lei X., Tan S.Y., Stanson K.P., Wei Z., Wong G.W.;
RT   "Skeletal muscle-derived myonectin activates the mammalian target of
RT   rapamycin (mTOR) pathway to suppress autophagy in liver.";
RL   J. Biol. Chem. 288:36073-36082(2013).
RN   [13]
RP   INTERACTION WITH GKAP1.
RX   PubMed=25586176; DOI=10.1074/jbc.m114.624759;
RA   Ando Y., Shinozawa Y., Iijima Y., Yu B.C., Sone M., Ooi Y., Watanaka Y.,
RA   Chida K., Hakuno F., Takahashi S.;
RT   "Tumor necrosis factor (TNF)-alpha-induced repression of GKAP42 protein
RT   levels through cGMP-dependent kinase (cGK)-Ialpha causes insulin resistance
RT   in 3T3-L1 adipocytes.";
RL   J. Biol. Chem. 290:5881-5892(2015).
RN   [14]
RP   INTERACTION WITH DGKZ.
RX   PubMed=27739494; DOI=10.1038/srep35438;
RA   Liu T., Yu B., Kakino M., Fujimoto H., Ando Y., Hakuno F., Takahashi S.I.;
RT   "A novel IRS-1-associated protein, DGKzeta regulates GLUT4 translocation in
RT   3T3-L1 adipocytes.";
RL   Sci. Rep. 6:35438-35438(2016).
CC   -!- FUNCTION: May mediate the control of various cellular processes by
CC       insulin. When phosphorylated by the insulin receptor binds specifically
CC       to various cellular proteins containing SH2 domains such as
CC       phosphatidylinositol 3-kinase p85 subunit or GRB2. Activates
CC       phosphatidylinositol 3-kinase when bound to the regulatory p85 subunit.
CC       {ECO:0000269|PubMed:1380456}.
CC   -!- SUBUNIT: Interacts with SOCS7 (By similarity). Interacts (via IRS-type
CC       PTB domain) with IGF1R and INSR (via the tyrosine-phosphorylated NPXY
CC       motif) (By similarity). Interacts with UBTF, FER and PIK3CA (By
CC       similarity). Interacts (via phosphorylated YXXM motifs) with PIK3R1
CC       (PubMed:1380456). Interacts with ROCK1 (PubMed:11739394). Interacts
CC       (via PH domain) with PHIP (PubMed:11018022). Interacts with GRB2
CC       (PubMed:8491186). Interacts with ALK (By similarity). Interacts with
CC       EIF2AK2/PKR (By similarity). Interacts with GKAP1 (PubMed:25586176).
CC       Interacts with DGKZ in the absence of insulin; insulin stimulation
CC       decreases this interaction (PubMed:27739494). Found in a ternary
CC       complex with DGKZ and PIP5K1A in the absence of insulin stimulation (By
CC       similarity). Interacts with SQSTM1; the interaction is disrupted by the
CC       presence of tensin TNS2 (By similarity). {ECO:0000250|UniProtKB:P35568,
CC       ECO:0000250|UniProtKB:P35569, ECO:0000269|PubMed:11018022,
CC       ECO:0000269|PubMed:11739394, ECO:0000269|PubMed:1380456,
CC       ECO:0000269|PubMed:25586176, ECO:0000269|PubMed:27739494,
CC       ECO:0000269|PubMed:8491186}.
CC   -!- INTERACTION:
CC       P35570; Q9EPH8: Pabpc1; NbExp=2; IntAct=EBI-520230, EBI-919825;
CC       P35570; Q63787: Pik3r1; NbExp=2; IntAct=EBI-520230, EBI-518443;
CC       P35570; P39688: Fyn; Xeno; NbExp=4; IntAct=EBI-520230, EBI-524514;
CC       P35570; P62993: GRB2; Xeno; NbExp=5; IntAct=EBI-520230, EBI-401755;
CC       P35570; P06213: INSR; Xeno; NbExp=5; IntAct=EBI-520230, EBI-475899;
CC       P35570; Q8VDD9: Phip; Xeno; NbExp=2; IntAct=EBI-520230, EBI-1369766;
CC       P35570; P27986: PIK3R1; Xeno; NbExp=2; IntAct=EBI-520230, EBI-79464;
CC       P35570; Q04759: PRKCQ; Xeno; NbExp=2; IntAct=EBI-520230, EBI-374762;
CC       P35570; P18031: PTPN1; Xeno; NbExp=3; IntAct=EBI-520230, EBI-968788;
CC       P35570; Q06124: PTPN11; Xeno; NbExp=3; IntAct=EBI-520230, EBI-297779;
CC       P35570; Q13625-2: TP53BP2; Xeno; NbExp=4; IntAct=EBI-520230, EBI-287091;
CC   -!- PTM: Serine phosphorylation of IRS1 is a mechanism for insulin
CC       resistance. Ser-307 phosphorylation inhibits insulin action through
CC       disruption of IRS1 interaction with the insulin receptor, and Ser-789
CC       phosphorylation is increased in the liver of insulin-resistant rats
CC       (PubMed:11606564, PubMed:12006586, PubMed:7504175). Phosphorylation of
CC       Tyr-895 is required for GRB2-binding. Phosphorylated by ALK.
CC       Phosphorylated at Ser-265, Ser-302, Ser-632 and Ser-1100 by RPS6KB1;
CC       phosphorylation induces accelerated degradation of IRS1 (By
CC       similarity). Phosphorylated on tyrosine residues in response to insulin
CC       (By similarity). In skeletal muscles, dephosphorylated on Tyr-608 by
CC       TNS2 under anabolic conditions; dephosphorylation results in the
CC       proteasomal degradation of IRS1 (By similarity).
CC       {ECO:0000250|UniProtKB:P35568, ECO:0000250|UniProtKB:P35569,
CC       ECO:0000269|PubMed:11606564, ECO:0000269|PubMed:12006586,
CC       ECO:0000269|PubMed:7504175}.
CC   -!- PTM: Ubiquitinated by the Cul7-RING(FBXW8) complex in a mTOR-dependent
CC       manner, leading to its degradation: the Cul7-RING(FBXW8) complex
CC       recognizes and binds IRS1 previously phosphorylated by S6 kinase
CC       (RPS6KB1 or RPS6KB2). {ECO:0000250}.
CC   -!- PTM: S-nitrosylation at by BLVRB inhibits its activity.
CC       {ECO:0000250|UniProtKB:P35568}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X58375; CAA41264.1; -; mRNA.
DR   PIR; S16948; S16948.
DR   RefSeq; NP_037101.1; NM_012969.1.
DR   PDB; 5WRK; X-ray; 2.62 A; P=607-614.
DR   PDB; 5WRL; X-ray; 3.10 A; P=627-634.
DR   PDB; 5WRM; X-ray; 2.60 A; P=657-664.
DR   PDBsum; 5WRK; -.
DR   PDBsum; 5WRL; -.
DR   PDBsum; 5WRM; -.
DR   AlphaFoldDB; P35570; -.
DR   BMRB; P35570; -.
DR   SMR; P35570; -.
DR   BioGRID; 247500; 14.
DR   CORUM; P35570; -.
DR   DIP; DIP-664N; -.
DR   ELM; P35570; -.
DR   IntAct; P35570; 23.
DR   MINT; P35570; -.
DR   STRING; 10116.ENSRNOP00000019579; -.
DR   BindingDB; P35570; -.
DR   ChEMBL; CHEMBL1163110; -.
DR   GlyGen; P35570; 4 sites, 1 O-linked glycan (4 sites).
DR   iPTMnet; P35570; -.
DR   PhosphoSitePlus; P35570; -.
DR   PaxDb; 10116-ENSRNOP00000019579; -.
DR   GeneID; 25467; -.
DR   KEGG; rno:25467; -.
DR   UCSC; RGD:2922; rat.
DR   AGR; RGD:2922; -.
DR   CTD; 3667; -.
DR   RGD; 2922; Irs1.
DR   eggNOG; ENOG502QUNU; Eukaryota.
DR   InParanoid; P35570; -.
DR   OrthoDB; 4212441at2759; -.
DR   PhylomeDB; P35570; -.
DR   Reactome; R-RNO-109704; PI3K Cascade.
DR   Reactome; R-RNO-112399; IRS-mediated signalling.
DR   Reactome; R-RNO-112412; SOS-mediated signalling.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1266695; Interleukin-7 signaling.
DR   Reactome; R-RNO-198203; PI3K/AKT activation.
DR   Reactome; R-RNO-201556; Signaling by ALK.
DR   Reactome; R-RNO-2428928; IRS-related events triggered by IGF1R.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-74713; IRS activation.
DR   Reactome; R-RNO-74749; Signal attenuation.
DR   Reactome; R-RNO-9842663; Signaling by LTK.
DR   PRO; PR:P35570; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005901; C:caveola; ISO:RGD.
DR   GO; GO:0036064; C:ciliary basal body; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005899; C:insulin receptor complex; IMP:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005158; F:insulin receptor binding; IMP:RGD.
DR   GO; GO:0005159; F:insulin-like growth factor receptor binding; IPI:RGD.
DR   GO; GO:0141038; F:phosphatidylinositol 3-kinase activator activity; ISO:RGD.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; IDA:UniProtKB.
DR   GO; GO:0001784; F:phosphotyrosine residue binding; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:RGD.
DR   GO; GO:0019901; F:protein kinase binding; IPI:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IPI:BHF-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0030674; F:protein-macromolecule adaptor activity; ISO:RGD.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:UniProtKB.
DR   GO; GO:0035591; F:signaling adaptor activity; ISO:RGD.
DR   GO; GO:0030159; F:signaling receptor complex adaptor activity; ISO:RGD.
DR   GO; GO:0005068; F:transmembrane receptor protein tyrosine kinase adaptor activity; IMP:BHF-UCL.
DR   GO; GO:0016477; P:cell migration; ISO:RGD.
DR   GO; GO:1904385; P:cellular response to angiotensin; IEP:RGD.
DR   GO; GO:1990416; P:cellular response to brain-derived neurotrophic factor stimulus; IEP:RGD.
DR   GO; GO:0071398; P:cellular response to fatty acid; ISO:RGD.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISO:RGD.
DR   GO; GO:0071478; P:cellular response to radiation; IEP:RGD.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0010631; P:epithelial cell migration; ISO:RGD.
DR   GO; GO:0008286; P:insulin receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0048009; P:insulin-like growth factor receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0016042; P:lipid catabolic process; ISO:RGD.
DR   GO; GO:0030879; P:mammary gland development; ISO:RGD.
DR   GO; GO:0046627; P:negative regulation of insulin receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; IMP:BHF-UCL.
DR   GO; GO:0090275; P:negative regulation of somatostatin secretion; IMP:BHF-UCL.
DR   GO; GO:0043491; P:phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:0032000; P:positive regulation of fatty acid beta-oxidation; ISO:RGD.
DR   GO; GO:0070094; P:positive regulation of glucagon secretion; IMP:BHF-UCL.
DR   GO; GO:0046326; P:positive regulation of glucose import; ISO:RGD.
DR   GO; GO:0010907; P:positive regulation of glucose metabolic process; ISO:RGD.
DR   GO; GO:0045725; P:positive regulation of glycogen biosynthetic process; ISO:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; IDA:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:BHF-UCL.
DR   GO; GO:0034504; P:protein localization to nucleus; ISO:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0014823; P:response to activity; IEP:RGD.
DR   GO; GO:0031000; P:response to caffeine; IDA:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   CDD; cd01257; PH_IRS; 1.
DR   CDD; cd01204; PTB_IRS; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   InterPro; IPR039011; IRS.
DR   InterPro; IPR002404; IRS_PTB.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR10614; INSULIN RECEPTOR SUBSTRATE; 1.
DR   PANTHER; PTHR10614:SF11; INSULIN RECEPTOR SUBSTRATE 1; 1.
DR   Pfam; PF02174; IRS; 1.
DR   Pfam; PF00169; PH; 1.
DR   PRINTS; PR00628; INSULINRSI.
DR   SMART; SM01244; IRS; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00310; PTBI; 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS51064; IRS_PTB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Phosphoprotein;
KW   Reference proteome; Repeat; S-nitrosylation; Transducer; Ubl conjugation.
FT   CHAIN           1..1235
FT                   /note="Insulin receptor substrate 1"
FT                   /id="PRO_0000084238"
FT   DOMAIN          12..115
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          155..259
FT                   /note="IRS-type PTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00389"
FT   REGION          3..133
FT                   /note="Mediates interaction with PHIP"
FT                   /evidence="ECO:0000269|PubMed:11018022"
FT   REGION          258..425
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          520..539
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          669..720
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          766..921
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          895..897
FT                   /note="GRB2-binding"
FT   REGION          1024..1165
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1177..1235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           460..463
FT                   /note="YXXM motif 1"
FT   MOTIF           546..549
FT                   /note="YXXM motif 2"
FT   MOTIF           608..611
FT                   /note="YXXM motif 3"
FT   MOTIF           628..631
FT                   /note="YXXM motif 4"
FT   MOTIF           658..661
FT                   /note="YXXM motif 5"
FT   MOTIF           727..730
FT                   /note="YXXM motif 6"
FT   MOTIF           939..942
FT                   /note="YXXM motif 7"
FT   MOTIF           987..990
FT                   /note="YXXM motif 8"
FT   MOTIF           1010..1013
FT                   /note="YXXM motif 9"
FT   COMPBIAS        261..276
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        288..311
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        362..425
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        521..539
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        669..693
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        769..783
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        784..812
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        867..887
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1029..1052
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1070..1088
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1191..1205
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1206..1229
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         3
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         99
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:8349691"
FT   MOD_RES         265
FT                   /note="Phosphoserine; by RPS6KB1"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         302
FT                   /note="Phosphoserine; by RPS6KB1"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         307
FT                   /note="Phosphoserine; by IKKB, MAPK8 and RPS6KB1"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         318
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         325
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35569"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35569"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         414
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35569"
FT   MOD_RES         441
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         448
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         460
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         502
FT                   /note="Phosphothreonine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:8349691"
FT   MOD_RES         522
FT                   /note="Phosphoserine; by RPS6KB1"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         608
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         612
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:24187137"
FT   MOD_RES         628
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         632
FT                   /note="Phosphoserine; by RPS6KB1 and ROCK2"
FT                   /evidence="ECO:0000250|UniProtKB:P35569"
FT   MOD_RES         658
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         789
FT                   /note="Phosphoserine; by AMPK and SIK2"
FT                   /evidence="ECO:0000269|PubMed:12006586"
FT   MOD_RES         891
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         895
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         939
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         987
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         1099
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35569"
FT   MOD_RES         1100
FT                   /note="Phosphoserine; by RPS6KB1"
FT                   /evidence="ECO:0000250|UniProtKB:P35568"
FT   MOD_RES         1172
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MOD_RES         1222
FT                   /note="Phosphotyrosine; by INSR"
FT                   /evidence="ECO:0000269|PubMed:7504175"
FT   MUTAGEN         106
FT                   /note="W->A: Loss of interaction with PHIP."
FT                   /evidence="ECO:0000269|PubMed:11018022"
FT   CONFLICT        1098
FT                   /note="H -> L (in Ref. 2; AA sequence)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1235 AA;  131178 MW;  A274BC7540CA85C5 CRC64;
     MASPPDTDGF SDVRKVGYLR KPKSMHKRFF VLRAASEAGG PARLEYYENE KKWRHKSSAP
     KRSIPLESCF NINKRADSKN KHLVALYTRD EHFAIAADSE AEQDSWYQAL LQLHNRAKAH
     HDGAGGGCGG SCSGSSGVGE AGEDLSYDTG PGPAFKEVWQ VILKPKGLGQ TKNLIGIYRL
     CLTSKTISFV KLNSEAAAVV LQLMNIRRCG HSENFFFIEV GRSAVTGPGE FWMQVDDSVV
     AQNMHETILE AMRAMSDEFR PRTKSQSSSS CSNPISVPLR RHHLNNPPPS QVGLTRRSRT
     ESITATSPAS MVGGKPGSFR VRASSDGEGT MSRPASVDGS PVSPSTNRTH AHRHRGSSRL
     HPPLNHSRSI PMPSSRCSPS ATSPVSLSSS STSGHGSTSD CLFPRRSSAS VSGSPSDGGF
     ISSDEYGSSP CDFRSSFRSV TPDSLGHTPP ARGEEELSNY ICMGGKGAST LTAPNGHYIL
     SRGGNGHRYI PGATMGTSPA LTGDEAAGAA DLDNRFRKRT HSAGTSPTIS HQKTPSQSSV
     VSIEEYTEMM PAAYPPGGGS GGRLPGYRHS AFVPTHSYPE EGLEMHHLER RGGHHRPDSS
     NLHTDDGYMP MSPGVAPVPS NRKGNGDYMP MSPKSVSAPQ QIINPIRRHP QRVDPNGYMM
     MSPSGSCSPD IGGGSCSSSS ISAAPSGSSY GKPWTNGVGG HHTHALPHAK PPVESGGGKL
     LPCTGDYMNM SPVGDSNTSS PSECYYGPED PQHKPVLSYY SLPRSFKHTQ RPGEPEEGAR
     HQHLRLSSSS GRLRYTATAE DSSSSTSSDS LGGGYCGARP ESSVTHPHHH ALQPHLPRKV
     DTAAQTNSRL ARPTRLSLGD PKASTLPRVR EQQQQQQQQQ QSSLHPPEPK SPGEYVNIEF
     GSGQPGYLAG PATSRSSPSV RCLPQLHPAP REETGSEEYM NMDLGPGRRA TWQESGGVEL
     GRVGPAPPGA ASICRPTRSV PNSRGDYMTM QIGCPRQSYV DTSPVAPVSY ADMRTGIAAE
     KVSLPRTTGA APPPSSTASA SASVTPQGAA EQAAHSSLLG GPQGPGGMSA FTRVNLSPNH
     NQSAKVIRAD TQGCRRRHSS ETFSAPTRAA NTVSFGAGAA GGGSGGGSED VKRHSSASFE
     NVWLRPGDLG GASKESAPGC GAAGGLEKSL NYIDLDLVKD VKQHPQDCPS QQQSLPPPPP
     HQPLGSNEGS SPRRSSEDLS TYASINFQKQ PEDRQ
//
